Vps35缺陷损害Cdk5/p35降解并促进视网膜神经节细胞Tau蛋白过度磷酸化
本研究以原代视网膜神经节细胞(RGCs)及大鼠视网膜谷氨酸兴奋性毒性模型为对象,探讨Vps35缺陷导致tau过度磷酸化的机制。结果显示Vps35下调增加p35表达和tau过度磷酸化,Cdk5抑制剂roscovitine可降低该磷酸化水平;Vps35抑制通过影响p35溶酶体降解增强Cdk5/p35活性并导致RGC变性。
要点
- Vps35下调增加p35表达和tau过度磷酸化,过表达则相反。
- Cdk5抑制剂roscovitine可有效降低Vps35缺陷诱导的tau过度磷酸化。
- Vps35抑制通过影响p35溶酶体降解增强Cdk5/p35活性并导致RGC变性。
核心结论
- Vps35缺陷通过影响p35的溶酶体降解增强Cdk5/p35活性,促进tau过度磷酸化并导致RGC变性。
- Cdk5/p35可能作为Vps35的「货物」,Vps35是RGC变性潜在靶点。
研究设计与样本
- 研究使用原代视网膜神经节细胞(RGCs),并在体内采用大鼠视网膜谷氨酸兴奋性毒性模型。
- 在不同时间点收集新鲜视网膜组织或眼球,通过免疫荧光染色、Western blotting和免疫沉淀研究Vps35、Cdk5/p35、tau过度磷酸化、LAMP1、EEA1和UBE1的表达与相互作用。
主要发现
- Vps35下调和过表达分别增加和降低p35表达及tau过度磷酸化。
- Cdk5抑制剂roscovitine可有效降低Vps35缺陷诱导的过度磷酸化tau水平。
- 抑制Vps35可通过影响p35的溶酶体降解增加Cdk5/p35活性,并导致RGC变性。
临床怎么用
- Vps35/Cdk5/p35通路可能作为青光眼等眼部疾病中RGC变性的基础研究与临床治疗潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Vacuolar protein sorting 35 (Vps35) mutations and protein dysfunction have been linked to the hyperphosphorylation and accumulation of tau protein in a number of central neurodegenerative disorders. The aims of the present study were to investigate the mechanism underlying the tau hyperphosphorylation caused by Vps35 deficiency. METHODS: The cells used in this study were primary retinal ganglion cells (RGCs). The rat retinal glutamate excitotoxicity model was used in vivo. Fresh retinal tissues or eyeballs were collected at different time points. The expression and interactions of Vps35, Cdk5/p35, tau hyperphosphorylation, LAMP1, EEA1 and UBE1 in RGCs were studied by immunofluorescence staining, Western blotting, and immunoprecipitation. RESULTS: The downregulation and overexpression of Vps35 increased and decreased the expression of p35 and tau hyperphosphorylation, respectively. More important, roscovitine, a Cdk5 inhibitor, could effectively decrease the hyperphosphorylated tau level induced by Vps35 deficiency. Furthermore, this study confirmed that the inhibition of Vps35 could increase the activity of Cdk5/p35 by affecting the lysosomal degradation of p35 and lead to the degeneration of RGCs. CONCLUSIONS: These findings demonstrate the possibility that Cdk5/p35 acts as a "cargo" of Vps35 and provide new insights into the pathogenesis of RGC degeneration caused by hyperphosphorylated tau protein. Vps35 is a potential target for basic research and clinical treatment of RGC degeneration in many ocular diseases such as glaucoma.
引用
- Gao L, Xiao H, Ai LQ, et al. Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells. Invest Ophthalmol Vis Sci. 2020. PMID: 31995153. doi:10.1167/iovs.61.1.1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。